Sun Pharmaceutical Industries Limited
SUNPHARMA
Rankning i aktier
#526
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Aktiekurs
$19.24
Senast synkroniserad: 2026-10-19
Marknadsvärde
$46.15B
Förändring (1 dag)
-0.97%
Förändring (1 år)
0.16%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategori
Healthcare
Antal utestående aktier för Sun Pharmaceutical Industries Limited (SUNPHARMA)
Antal utestående aktier per June 2026: 2.40B
Enligt de senaste finansiella rapporterna och aktiekursen för Sun Pharmaceutical Industries Limited är det aktuella antalet utestående aktier 2.40B. I slutet av March 2024 hade företaget 2.40B utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Sun Pharmaceutical Industries Limited (SUNPHARMA) från 2004 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 2.40B | 0.11% |
| 2025 | 2.40B | -0.11% |
| 2024 | 2.40B | 0.00% |
| 2023 | 2.40B | 0.00% |
| 2022 | 2.40B | 0.00% |
| 2021 | 2.40B | 0.00% |
| 2020 | 2.40B | 0.00% |
| 2019 | 2.40B | 0.00% |
| 2018 | 2.40B | -0.17% |
| 2017 | 2.40B | -0.13% |
| 2016 | 2.41B | 0.06% |
| 2015 | 2.40B | 16.12% |
| 2014 | 2.07B | 0.00% |
| 2013 | 2.07B | 0.00% |
| 2012 | 2.07B | 0.00% |
| 2011 | 2.07B | 0.00% |
| 2010 | 2.07B | 0.00% |
| 2009 | 2.07B | 4.00% |
| 2008 | 1.99B | 5.99% |
| 2007 | 1.88B | 1.29% |
| 2006 | 1.86B | 0.00% |
| 2005 | 1.86B | 0.00% |
| 2004 | 1.86B | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
